In ovarian cancer, miR-424–5p inhibits mitochondrial elongation factor 2 (MIEF2), which regulates mitochondrial fission, inhibits glucose metabolism from oxidative phosphorylation to glycolysis, and inhibits tumor growth (Zhao et al., 2020). Here, MIEF2 is linked to ovarian carcinoma.